The prognostic role of horizontal and circumferential tumor extent in cervical cancer: Implications for the 2019 FIGO staging system.

CONCLUSIONS: HZTE is an independent predictor of survival in cervical carcinoma. In stage IA tumors, however, HZTE does not offer superior prognostic value, supporting the 2019 FIGO recommendations to remove this variable from staging in these cases. HZTE may be useful in larger tumors in which staging depends on maximum tumor size. %CTE is not an independent prognostic variable in cervical cancer, and we advise against its use. PMID: 32471646 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32471646?dopt=Abstract

Source: Gynecologic Oncology - May 25, 2020 Category: Cancer & Oncology Authors: Zyla RE, Gien LT, Vicus D, Olkhov-Mitsel E, Mirkovic J, Nofech-Mozes S, Djordjevic B, Parra-Herran C Tags: Gynecol Oncol Source Type: research